from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2287/yjcE

LFCtreatmentdescriptionclass of inhibitor

-1.264

Amikacinug/mL Amikacintranslation

-1.244

Cap5-10ug/mL Capreomycintranslation

-2.095

Rox10-50 ug/mL Roxithromycintranslation

-0.123

SM2-5 ug/mL Streptomycintranslation

-2.436

Tet5-10 ug/mL Tetracyclinetranslation

-0.212

Rif0.2-5ug/mL Rifampicintranscription

-0.646

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.135

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.823

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.022

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.080

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.582

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.180

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.743

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.748

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.507

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.567

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.158

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.926

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.855

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.430

KCN5-20 ug/mL Potassium cyaniderespiration

-0.626

NaN30.2-2 mM Sodium aziderespiration

0.036

Nigericin50 uM Nigericinrespiration

-0.573

TRC10-150 ug/mL Triclosanrespiration

0.637

TRZ10-25 ug/mL Thioridazinerespiration

-0.642

Valinomycin0.5-10 uM Valinomycinrespiration

0.187

ZnSO42 mM ZnSO4respiration

-0.621

menadione6-10 ug/mL Menadionerespiration

1.904

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.307

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.910

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.094

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.041

NRP_1Non-replicating persistence stage 1dosRassociated

0.674

Amp0.2mg/mL AmpicillincellWall

0.333

Cephalexin20-100 ug/mL CephalexincellWall

-0.443

Cerulenin0.32-5 ug/mL CerulenincellWall

0.680

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

1.201

EMB10-20 ug/mL EthambutolcellWall

0.806

Eta12-40 ug/mL EthionamidecellWall

0.759

INH0.2-0.4 ug/mL IsoniazidcellWall

0.174

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.359

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.139

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.036

BZA0.12 mg/mL BenzamidearomaticAmides

-0.887

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.570

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.455

H2O24 mM hydrogen peroxideDNAdamaging

0.757

Levo10 ug/mL LevofloxacinDNAdamaging

0.187

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.082

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.336

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.225

UVUV-irradiationDNAdamaging

0.484

ARP41-4 ug/mL Antitubercular compound ARP4?

1.686

Antimycin12.5-50 ug/mL Antimycin A?

-0.017

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.991

PA_110-50 ug/mL Antitubercular compound PA-1?

1.008

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.317

PA8240.2-2 ug/mL PA-824?

0.959

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.232

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.200

Verapamil50 uM Verapamil?

-0.396

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.240

methoxatin10-20 ug/mL Methoxatin?